AUPP182398A0 - Cyclic peptide inhibitors of pla2 - Google Patents

Cyclic peptide inhibitors of pla2

Info

Publication number
AUPP182398A0
AUPP182398A0 AUPP1823A AUPP182398A AUPP182398A0 AU PP182398 A0 AUPP182398 A0 AU PP182398A0 AU PP1823 A AUPP1823 A AU PP1823A AU PP182398 A AUPP182398 A AU PP182398A AU PP182398 A0 AUPP182398 A0 AU PP182398A0
Authority
AU
Australia
Prior art keywords
pla2
cyclic peptide
peptide inhibitors
inhibitors
cyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP1823A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Garvan Institute of Medical Research
Original Assignee
Garvan Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Garvan Institute of Medical Research filed Critical Garvan Institute of Medical Research
Priority to AUPP1823A priority Critical patent/AUPP182398A0/en
Publication of AUPP182398A0 publication Critical patent/AUPP182398A0/en
Priority to AU26042/99A priority patent/AU2604299A/en
Priority to PCT/AU1999/000087 priority patent/WO1999041278A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AUPP1823A 1998-02-13 1998-02-13 Cyclic peptide inhibitors of pla2 Abandoned AUPP182398A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPP1823A AUPP182398A0 (en) 1998-02-13 1998-02-13 Cyclic peptide inhibitors of pla2
AU26042/99A AU2604299A (en) 1998-02-13 1999-02-15 Cyclic peptide inhibitors of pla2
PCT/AU1999/000087 WO1999041278A1 (en) 1998-02-13 1999-02-15 Cyclic peptide inhibitors of pla2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP1823A AUPP182398A0 (en) 1998-02-13 1998-02-13 Cyclic peptide inhibitors of pla2

Publications (1)

Publication Number Publication Date
AUPP182398A0 true AUPP182398A0 (en) 1998-03-12

Family

ID=3806091

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP1823A Abandoned AUPP182398A0 (en) 1998-02-13 1998-02-13 Cyclic peptide inhibitors of pla2

Country Status (2)

Country Link
AU (1) AUPP182398A0 (en)
WO (1) WO1999041278A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS282602A0 (en) * 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
US11154587B2 (en) 2015-10-09 2021-10-26 Diaccurate Use of peptides to stimulate the immune system
JP7307681B2 (en) * 2017-02-17 2023-07-12 カムリス インターナショナル インコーポレイテッド general purpose antitoxin
EP3530282A1 (en) * 2018-02-27 2019-08-28 Diaccurate Therapeutic methods
EP3693063A1 (en) * 2019-02-06 2020-08-12 Diaccurate Methods and compositions for treating cancer
US20230270817A1 (en) * 2020-07-22 2023-08-31 Filamon Pty Ltd Vimentin inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU668513B2 (en) * 1991-07-04 1996-05-09 Kieran Francis Scott PLA2 inhibitory compounds
AU4371297A (en) * 1996-09-27 1998-04-17 Garvan Institute Of Medical Research Inhibitors of pla2

Also Published As

Publication number Publication date
WO1999041278A1 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
IL137540A0 (en) Inhibitors of phospholipase a2
IL137719A0 (en) Inhibitors of phospholipase enzymes
PL342995A1 (en) Inhibitors of phospholipase enzymes
AUPP616498A0 (en) Synthesis of cyclic peptides
AU3665199A (en) Inhibitors of impdh enzyme
AU4429799A (en) Inhibitors of p38
AU4677399A (en) Inhibitors of H+K+-ATPase
AU2805897A (en) Inhibitors of protein farnesyltransferase
EP1127054A4 (en) Novel inhibitors of impdh enzyme
AU7371998A (en) Inhibitors of protein isoprenyl transferases
AU6311996A (en) Peptide inhibitors of fibronectine
AU6174696A (en) Inhibitors of phospholipase a2
AU3826899A (en) Peptide analogues of pacap
AU6111000A (en) Inhibitors of viral helcase
AU5619400A (en) Statine-derived tetrapeptide inhibitors of beta-secretase
AU3789399A (en) Indolicidin analogs and methods of using same
WO2000053169A8 (en) Method of inhibiting a chaperone protein
AU772782C (en) Cyclic peptide derivatives as inhibitors of integrin alphavbeta6
AU8673598A (en) Neuraminidase inhibitors
AUPP182398A0 (en) Cyclic peptide inhibitors of pla2
AU2354800A (en) Method of protein removal
AU2241699A (en) Expression of proteolytically-sensitive peptides
AU2373600A (en) Novel spla2 inhibitors
HUP0104178A3 (en) Enzymatic amidation of peptides
AU5673099A (en) Inhibitors of amyloid formation